We report the development of hypothermia in a patient with Hodgkin lymphoma which resolved with chemotherapy administration. A review of the literature revealed 16 previous reports of hypothermia in patients with Hodgkin lymphoma. Overall prognosis seems to be unfavorable. To the best of our knowledge this is the first report of hypothermia in a patient with Hodgkin lymphoma transforming from chronic lymphocytic leukemia (Richter's syndrome). A possible pathophysiology could be paraneoplastic autonomic neuropathy. Physicians should be aware that Hodgkin lymphoma can present with hypothermia and should carefully monitor newly diagnosed patients with advanced disease for this complication. Likewise, patients with Hodgkin lymphoma who develop hypothermia should be screened for signs of autonomic neuropathy.

Keywords:
Autonomic neuropathy, Hodgkin lymphoma, Hypothermia
1.
Mcculluogh L, Arora S: Diagnosis and treatment of hypothermia. Am Fam Physician 2004;70:2325-2332.
2.
Buccini RV: Hypothermia in Hodgkin's disease. N Engl J Med 1985;312:244.
3.
Gabrys K, Mazur G: Hypothermia during chemotherapy for lymphomas. Pol Arch Med Wewn 1995;93:130-134.
4.
Jackson MJ, Proctor SJ, Leonard RCF: Hypothermia during chemotherapy for Hodgkin's disease. Br Med J 1983;286:1183-1184.
5.
Jung M, Koppensteiner R, Graninger W, Appel HW, Lackner F: Hypothermia in Hodgkin's disease after exploratory Laparotomy. Klin Wochenschr 1988;66:552-555.
6.
Koriech OM: Hypothermia and hypotension in Hodgkin's disease. Br Med J 1981;282:1582-1583.
7.
MacKenzie J: Hypothermia and hypotension in Hodgkin's disease. Br Med J 1981;283:139-140.
8.
Pattison CW: Hypothermia and hypotension in Hodgkin's disease (letter). Br Med J 1981;283:438.
9.
Van Lieshout JJ, Wieling W, Van Montfrans GA, Settels JJ, Speelman JD, Endert E, Karemaker JM: Acute autonomic neuropathy associated with Hodgkin's disease. J Neurol Neurosurg Psychiatry 1986;49:830-832.
10.
Weens JH, Hernandez B: Hypothermia following chemotherapy for Hodgkin's disease. Cancer Treat Rep 1986;70:313-314.
11.
Robin V, Lebacq J, Michaux L, Ferrant A: Hodgkins disease and hypothermia: case report and review of literature. Ann Hematology 2002;81:106-107.
12.
Kulkarni A, Zlabek J, Farnen J, Capla R: Recurrent hypothermia and hypoglycemia in a patient with Hodgkin's disease. Haematologica 2006;91(suppl 12):ECR50.
13.
Meert AP, Bherghmans T, Sculier JP: Hypothermia and Hodgkin disease: case report and review of literature. Acta Clin Belg 2006;61:252-254.
14.
Koksal Y, Caliskan U, Unal E: Hypothermia in a child with Hodgkin's disease. J Pediater Hematol Oncol 2009;31:136-138.
15.
Bilora F, Veronese F, Zancan A, Biasiolo M, Pomerri F, Muzzio PC: Autonomic dysfunction in Hodgkin and non-Hodgkin lymphoma: a paraneoplastic syndrome? Hematol Rep 2010;2:e8.
16.
Crespo M, Correia L, Ferreira F, Ducla-Soares JL: Acute dysautonomia associated to Hodgkin lymphoma. Acta Med Port 2002;15:153-154.
17.
Turner ML, Boland OM, Parker AC, Ewing DJ: Subclinical autonomic dysfunction in patients with Hodgkin disease and non-Hodgkin lymphoma. Br J Haematol 1993;84:623-626.
18.
Scott AR, MacDonald IA, Benett T, Tattersal RB: Abnormal thermoregulation in diabetic autonomic neuropathy. Diabetes 1988;37:961-968.
19.
Hansen SW: Autonomic neuropathy after treatment with cisplatin, vinblastine and bleomycin for germ cell tumor. BMJ 1990;300:511-512.
20.
Giometto B, Vitaliani R, Lindeck-Pozza E, Grisold W, Vedeler C: Treatment for paraneoplastic neuropathies. Cochrane Database Syst Rev 2012;12:CD007625.
© 2013 S. Karger AG, Basel
2013
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.